Target intelligence / Profile preview

Intestinal tight junction proteins (TJ proteins)

Target
TJ proteins
Molecular classification
Cell adhesion molecules, Structural proteins, Barrier proteins, Other
01

Overview

Intestinal tight junction proteins are a complex network of transmembrane and cytosolic proteins, including claudins, occludin, and zonula occludens (ZO) proteins, that form a semi-permeable barrier between intestinal epithelial cells (StatPearls, NBK535377). These proteins regulate the paracellular transport of ions and solutes while preventing the translocation of luminal antigens and pathogens into the systemic circulation (PubMed, 28846513). In diseases like Celiac disease and Inflammatory Bowel Disease (IBD), the integrity of these junctions is compromised, leading to increased intestinal permeability or "leaky gut" (PubMed, 31076401). Therapeutic agents like Larazotide acetate target these components by antagonizing zonulin, a modulator that increases permeability, thereby restoring the intestinal barrier (DrugBank, DB06273). Maintaining the stability of these proteins is crucial for immune homeostasis and preventing chronic inflammatory responses (PubMed, 23426535). This target entry is marked as incorrect because "intestinal mucosa proteins" is an overly broad category encompassing thousands of distinct proteins, whereas "tight junction components" refers to a specific functional complex.

Other names
Tight junction complexZonula occludensParacellular barrier proteinsIntestinal mucosal barrier proteinsApical junctional complex
02

Mechanism of action

Tight junction modulation, Zonulin antagonism, Enhancement of epithelial barrier integrity, Regulation of paracellular permeability

03

Biological functions

Barrier functionParacellular transportCell polaritySignal transductionImmune response
04

Disease associations

InflammationCeliac diseaseInflammatory Bowel Disease (IBD)Irritable Bowel Syndrome (IBS)Type 1 DiabetesInfection
05

Safety considerations

Potential for systemic absorption of luminal toxins or pathogens if barrier integrity is compromisedRisk of malabsorption of essential nutrients if paracellular pathways are overly restrictedOff-target effects on other epithelial or endothelial barriers such as the blood-brain barrierPotential for chronic immune activation if barrier restoration is incomplete
06

Interacting drugs

Larazotide acetate

5 more in the full profile.

07

Biomarkers

Serum Zonulin levelsClaudin-3 expressionLactulose/Mannitol ratioTransepithelial electrical resistance (TEER)Intestinal Fatty Acid Binding Protein (I-FABP)

Beyond the preview

Go deeper on Intestinal tight junction proteins (TJ proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal tight junction proteins (TJ proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call